Cargando…

Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer

Research has been driven towards finding therapy predictive biomarkers for colorectal cancer (CRC) with a special interest in studying the gut microbiome. Gut microbiome acts not only as a barrier to prevent bacterial invasion and infection, but it also affects the efficacy of hematopoietic-cell tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Temraz, Sally, Nassar, Farah, Nasr, Rihab, Charafeddine, Maya, Mukherji, Deborah, Shamseddine, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747470/ https://www.ncbi.nlm.nih.gov/pubmed/31450712 http://dx.doi.org/10.3390/ijms20174155

Ejemplares similares

Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
por: Temraz, Sally, et al.
Publicado: (2021)

Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer
por: Baassiri, Amro, et al.
Publicado: (2020)

The Crosstalk between Microbiome and Immune Response in Gastric Cancer
por: Nasr, Rihab, et al.
Publicado: (2020)

Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer Patients
por: Nasr, Rihab, et al.
Publicado: (2018)

Trends in lung cancer incidence in Lebanon by gender and histological type over the period 2005–2008
por: Temraz, Sally, et al.
Publicado: (2017)

Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study
por: Temraz, Sally, et al.
Publicado: (2023)

Circulating miRNA as Biomarkers for Colorectal Cancer Diagnosis and Liver Metastasis
por: Nassar, Farah J., et al.
Publicado: (2021)

Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions
por: Kreidieh, Malek, et al.
Publicado: (2020)

Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications
por: El Halabi, Ibrahim, et al.
Publicado: (2018)

Potential Targets for Colorectal Cancer Prevention
por: Temraz, Sally, et al.
Publicado: (2013)

The unveiling of a new risk factor associated with bladder cancer in Lebanon
por: Temraz, Sally, et al.
Publicado: (2019)

Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers
por: Temraz, Sally, et al.
Publicado: (2015)

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021)

Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018
por: Shamseddine, Ali, et al.
Publicado: (2014)

Proportion of cancer in a Middle eastern country attributable to established risk factors
por: Charafeddine, Maya A., et al.
Publicado: (2017)

A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)
por: Elias, Charbel, et al.
Publicado: (2022)

The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study
por: Bouferraa, Youssef, et al.
Publicado: (2022)

Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis
por: Temraz, Sally, et al.
Publicado: (2014)

The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
por: Bouferraa, Youssef, et al.
Publicado: (2021)

Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort
por: El Chediak, Alissar, et al.
Publicado: (2017)

Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223
por: Mukherji, Deborah, et al.
Publicado: (2014)

Waterpipe Smoking among Bladder Cancer Patients: A Cross-Sectional Study of Lebanese and Jordanian Populations
por: Jabra, Elio, et al.
Publicado: (2021)

Sunitinib Induced Thrombotic Thrombocytopenic Purpura in addition to Severe Hypothyroidism: A Case Report and Review of the Literature
por: El Dika, Imane, et al.
Publicado: (2014)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Current Status and Future Perspectives of Immunotherapy in Middle-Income Countries: A Single-Center Early Experience
por: Bou Akl, Imad, et al.
Publicado: (2020)

Overcoming EGFR Resistance in Metastatic Colorectal Cancer Using Vitamin C: A Review
por: Machmouchi, Ahmad, et al.
Publicado: (2023)

Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity
por: Bouferraa, Youssef, et al.
Publicado: (2022)

Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese Population
por: Nasr, Rami, et al.
Publicado: (2017)

Primary synovial sarcoma of the kidney: a case report of complete pathological response at a Lebanese tertiary care center
por: El Chediak, Alissar, et al.
Publicado: (2018)

Insights on the Biomarker Potential of Exosomal Non-Coding RNAs in Colorectal Cancer: An In Silico Characterization of Related Exosomal lncRNA/circRNA–miRNA–Target Axis
por: Mezher, Maria, et al.
Publicado: (2023)

High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care center
por: Daher, Marilyne, et al.
Publicado: (2021)

A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon
por: Temraz, Sally, et al.
Publicado: (2022)

Increase in spleen volume as a predictor of oxaliplatin toxicity
por: El Chediak, Alissar, et al.
Publicado: (2018)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in Lebanon
por: Skelton, Mac, et al.
Publicado: (2020)

Management of colorectal cancer in the era of COVID-19: Challenges and suggestions
por: Alam, Walid, et al.
Publicado: (2021)

COVID-19 vaccination immune response in patients with solid organ and haematologic malignancies: call for active monitoring
por: Chehade, Laudy, et al.
Publicado: (2021)

Breast Cancer in Low- and Middle-Income Countries: An Emerging and Challenging Epidemic
por: Tfayli, Arafat, et al.
Publicado: (2010)

Giant Inflatable Colon Model Enhances Lebanese Community Knowledge and Intention for Colorectal Cancer Screening
por: Baassiri, Amro, et al.
Publicado: (2020)

The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
por: Oh, Byeongsang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rjnh9aqha95l8uldd6b2k14vot